BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, June 13, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 18, 2008

View Archived Issues

Human somatic cells can be induced into pluripotent stem cells without nuclear transfer

Read More

Neuroprotective effects of phosphorylated PRAS40 after spinal cord injury

Read More

New PPAR agonists described in recent patent

Read More

Novel diagnostic agents disclosed in recent patent from University of California, Oakland

Read More

Aastrom initiates patient treatment with stem cell therapy for dilated cardiomyopathy

Read More

Targeting the endothelin B receptor may improve the efficacy of tumor immune therapy

Read More

Intercell and PATH enter new collaboration for development of malaria vaccine

Read More

ActivBiotics extends deadline for sale of company assets until March 2008

Read More

Kamada announces completion of phase I studies with aerosolized alpha-1 antitrypsin

Read More

DelSite's nasal powder vaccine GelVac to move into phase I clinical trial later this year

Read More

Juvaris and Centers for Disease Control and Prevention enter agreement for H5N1 vaccine

Read More

Can-Fite expands studies to further investigate efficacy of CF-101 in treating uveitis

Read More

MAP completes SPA with FDA for phase III clinical trial of MAP-0004 for migraine

Read More

Cerimon initiates phase II/III trials of once-daily diclofenac sodium patch for pain

Read More

Novel treatment for spinal cord disorders reported in recent Sia Peptides patent

Read More

Denmark approves phase I clinical trials of PlGF antibody TB-403 in cancer

Read More

FDA approves ZymoGenetics' Recothrom commercialization

Read More

Schering-Plough files NDA for sugammadex in Japan

Read More

SGX announces that enrollment has begun in phase I clinical trials of SGX-523 for cancer

Read More

EPIX reports revised results from its phase IIa clinical trial of PRX-03140 in AD

Read More

XenoPort and GSK report top-line results for XP-13512 in the treatment of RLS

Read More

Shire launches Fosrenol in Spain, completing launch roll-out in E.U. markets

Read More

Dosing of Tracon's TRC-105 begins in cancer patients enrolled in a phase I trial

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 12, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 9, 2026
  • 3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

    Skape Bio unlocks GPCR targets with de novo-designed miniproteins

    BioWorld
    Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
  • Blood sample tubes after centrifuge

    Pre-disease plasma signature may help redefine lung cancer risk

    BioWorld
    Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
  • New 5-HT2C receptor agonists reported in Hansoh patent

    BioWorld Science
    Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing